Insights & Analysis

    The BioCompute Blog

    Expert perspectives on life sciences AI governance, regulatory compliance, and the technology shaping the future of bio-intelligence.

    All Articles

    technology

    Why GPU-Accelerated Compliance Changes Everything for Life Sciences

    BioCompute joins NVIDIA Inception to bring H100 GPU acceleration to regulatory evidence generation. Here's what that means for the future of life sciences AI.

    Mar 135 min read
    partnerships

    Building in Public: BioCompute's MaRS Momentum Journey

    Accepted into MaRS Momentum, Canada's premier growth accelerator. Here's what it means for BioCompute and the life sciences AI ecosystem.

    Mar 164 min read
    regulatory

    Why Your Life Sciences AI Platform Must Be HIPAA Compliant — And What That Actually Means

    HIPAA compliance for AI platforms goes far beyond encryption. Here's what life sciences organizations need to know about running AI workloads on protected health information.

    Mar 167 min read
    technology

    AI Audit Trails: The Foundation of Regulatory Compliance for Life Sciences AI

    Without a complete audit trail, your AI system is a black box to regulators. Here's how to build audit infrastructure that satisfies FDA, EU AI Act, and GxP requirements.

    Mar 169 min read
    regulatory

    What Is AI Governance? The Definitive Guide

    The authoritative guide to AI governance frameworks, regulatory requirements, and implementation for life sciences enterprises. Covers NIST AI RMF, ISO 42001, EU AI Act, and practical steps to deploy governance at scale.

    Apr 1118 min read
    technology

    AI Governance Platforms: Purpose-Built vs. Horizontal

    Compare purpose-built vs. horizontal AI governance platforms for life sciences. Includes a detailed feature comparison matrix, implementation timelines, and ROI analysis for regulated enterprises.

    Apr 1112 min read
    regulatory

    NIST AI RMF for Life Sciences: Practical Implementation

    Learn how to implement NIST AI Risk Management Framework in life sciences. Governance, risk mapping, measurement, and compliance strategies for 2026.

    Apr 1114 min read
    agentic-ai

    Claude Managed Agents for Life Sciences: Governance First

    Learn how to deploy Claude managed agents in pharma and biotech with built-in governance, audit compliance, and evidence collection.

    Apr 1112 min read
    enterprise-ai

    NVIDIA BioNeMo + BioCompute: Governed AI for Drug Discovery

    Learn how BioNeMo and BioCompute combine foundation models with governance to accelerate compliant drug discovery.

    Apr 1111 min read
    regulatory

    ISO 42001 for Pharma: AI Management Standard Explained

    Complete guide to ISO 42001 requirements for pharmaceutical companies. Understand how AI governance standards integrate with GxP and 21 CFR Part 11.

    Apr 1111 min read
    enterprise-ai

    Why Horizontal AI Governance Platforms Fail Life Sciences

    Learn why general-purpose AI governance platforms lack life sciences-specific controls. See how vertical approaches solve FDA, GxP, and audit requirements.

    Apr 1111 min read
    regulatory

    AI Compliance 2026: FDA, EU AI Act, HIPAA, GxP

    Comprehensive guide to AI compliance in life sciences: FDA SEQA, 21 CFR Part 11, EU AI Act, HIPAA, and GxP requirements. Deadlines, controls, and unified strategy.

    Apr 1122 min read
    Newsletter

    Sign Up for Updates

    AI governance insights for life sciences leaders.

    No spam. Unsubscribe anytime.